News

First Stop Health raises $6.5M for growth
By Laura Lovett | 02:41 pm | January 14, 2019
The latest funding round was led by Morningstar CEO Joe Mansueto and bswift CEO Rich Gallun. 
Israeli medical device cybersecurity company raises $7M
By Dave Muoio | 12:54 pm | January 14, 2019
The company said it would be using the money to fuel its push into North American markets.
NHS Chair Lord Prior talks challenges, opportunities of digital health tech
By Jonah Comstock | 12:47 pm | January 14, 2019
Part of the NHS's new 10-year plan is to make the organisation a testbed for new health tech, such as the portal-like HealthTech Connect.
Using voice content to live healthier lives
By HIMSS TV | 06:52 pm | January 11, 2019
.
Fixing the interoperability problem with data science
By HIMSS TV | 06:49 pm | January 11, 2019
.
The promises of consumer health data dominated CES 2019
By Dave Muoio | 05:47 pm | January 11, 2019
From on-stage demos to expo floor chit chat, attendees couldn't resist discussing what data collection and analysis could bring to consumer healthcare technology.
Seizure-detecting wearable Embrace2 cleared by FDA for use by children
By Jonah Comstock | 04:11 pm | January 11, 2019
The clearance is a first for the relatively underserved epilepsy wearable space.
Outcome Health COO: We’re a new, transparent company
By Dave Muoio | 12:33 pm | January 11, 2019
"This last year has been a year of rebuilding, creating infrastructure, [and] ensuring that we have all of the guardrails,"  Outcome Health's Nandini Ramani said at CES 2019.
US FDA grants breakthrough designation for AWAK’s Peritoneal Dialysis device
By Dean Koh | 03:02 am | January 11, 2019
Earlier this week, AWAK Technologies (AWAK), a Singapore-headquartered medical technology company focused on dialysis using regeneration technology for end-stage renal disease, announced that the US Food and Drug Administration (FDA) has granted Breakthrough Device designation to its AWAK Peritoneal Dialysis (AWAK PD) device, a wearable and ultra-portable PD system that incorporates AWAK’s patented sorbent technology.
Opportunities in precision oncology and genomic profiling services in Asia Pacific
By Dean Koh | 11:30 pm | January 10, 2019
Launched in 2010 with a $25 million Series A financing led by Third Rock Ventures, Foundation Medicine released its first commercial assay called FoundationOne in 2012.